Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways

6 Dec 2019

Abstract excerpt

Objective: Endometrial cancer (EC) is the second most common gynecological cancer worldwide. Myometrial invasion (MI) is a key event in EC dissemination. This study aimed to evaluate FXYD5/dysadherin (FXYD5/Dys) expression in EC tissue and uterine aspirate (UA) biopsies and to assess molecular/functional changes associated with its expression in cellular models. Methods: FXYD5/Dys messenger RNA (mRNA) levels were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Circular RNAs in diseases
Share to Endometrial and Cervical Cancer Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31867269
DOI: 10.3389/fonc.2019.01306

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB PathwaysPMID 31867269Read ↗

FBXO5 acts as a novel prognostic biomarker for patients with cervical cancerSemantic proximity Read ↗

Integrated Bioinformatic Analysis of DNA Methylation and Immune Infiltration in Endometrial CancerSemantic proximity Read ↗

Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genesSemantic proximity Read ↗

MECOM and the PRDM gene family in uterine endometrial cancer: bioinformatics and experimental insights into pathogenesis and therapeutic potentialsSemantic proximity Read ↗

LNCTAM34A promotes endometrial carcinoma progression through upregulation of C4orf47Semantic proximity Read ↗

CDKN2B-AS1 Promotes Malignancy as a Novel Prognosis-Related Molecular Marker in the Endometrial Cancer Immune MicroenvironmentSemantic proximity Read ↗

Whole genome sequencing of endometrial cancer identifies novel subgroups, drivers, and actionable alterationsSemantic proximity Read ↗

Integrated Bioinformatic Analysis of DNA Methylation and Immune Infiltration in Endometrial CancerSemantic proximity Read ↗

Dysadherin: A new player in cancer progressionSemantic proximity Read ↗

LINC00667 Inhibits the Progression of Endometrial Cancer by Regulating MAGEH1 and the BCL2-Mediated Apoptosis Signalling PathwaySemantic proximity Read ↗

Elevated histone demethylase KDM5C increases recurrent miscarriage risk by preventing trophoblast proliferation and invasionSemantic proximity Read ↗

Identification of Anoikis-Related Genes in Endometrial Cancer and Their Applications in Treatment Sensitivity and Prognostic EvaluationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.